4Front expands board with two new additions
Cannabis-focused investment firm 4Front Ventures Corp has appointed Kathi Lentzsch and Betty Aldworth to its board of directors. Lentzch is the CEO and president of Bartell Drugs while Aldworth is the executive director for Students for Sensible Drug Policy.
23 September 2019•4 mins read
